India–New Zealand FTA talks near finish after decade-long gap

India and New Zealand concluded a Free Trade Agreement in December 2025 after negotiations formally began in March 2025 — a turnaround of approximately nine ...

What Happened

India and New Zealand concluded a Free Trade Agreement in December 2025 after negotiations formally began in March 2025 — a turnaround of approximately nine months — ending a more than decade-long gap since initial FTA feasibility discussions lapsed.
The agreement is set for formal signing on April 27, 2026, with a bilateral trade target of USD 5 billion within five years against a current merchandise trade base of USD 1.3 billion (2024-25).
India's first formal institutional step toward an FTA with New Zealand — a Joint Study Group (JSG) — was established as early as 2007, indicating that the conceptual groundwork predated the resumed negotiations by nearly two decades.
The agreement grants 100% duty-free access for Indian exports to New Zealand across all tariff lines; New Zealand goods receive preferential access on 95% of Indian import lines, with sensitive sectors (dairy, onions, sugar, spices, edible oils, rubber) excluded.
A dedicated Agri-Technology Action Plan under the FTA focuses on kiwifruit, apples, and honey cooperation, supporting Indian farmers through improved planting materials, technical assistance, and capacity building.

Static Topic Bridges

Joint Study Groups and the Architecture of India's FTA Negotiations

India's FTA negotiation process typically begins with a Joint Study Group (JSG) — a bilateral mechanism that assesses the economic feasibility, potential gains, and sensitive sectors before formal negotiations begin. JSGs produce a feasibility report that forms the basis for the government's decision to launch negotiations. Following JSG recommendations, a Joint Working Group (JWG) or negotiating team is constituted. This phased approach can result in long gaps between initial feasibility assessment and actual agreement, as seen with the India–New Zealand FTA (JSG in 2007, formal negotiations in 2025) and the India–EU FTA (negotiations launched 2007, suspended 2013, relaunched 2022).

India's Department of Commerce (under the Ministry of Commerce and Industry) is the nodal ministry for FTA negotiations
JSGs typically cover goods, services, investments, intellectual property, and sanitary/phytosanitary standards
India has historically been conservative in FTA commitments — partly explaining the long gaps between JSG reports and concluded agreements
The faster pace of recent agreements (UAE CEPA in 2022, Australia ECTA in 2022, New Zealand FTA in 2025) reflects a revised negotiating strategy

Connection to this news: The 18-year gap between India's first JSG with New Zealand (2007) and actual negotiation completion (2025) illustrates both the complexity of FTA negotiations and India's historically cautious trade-opening approach; the nine-month conclusion timeline signals a deliberate acceleration.

Pharmaceutical Sector and Regulatory Harmonisation in FTAs

One of the high-value chapters in the India–New Zealand FTA is a pharmaceuticals and medical devices provision that enables New Zealand to accept GMP (Good Manufacturing Practice) and GCP (Good Clinical Practice) inspection reports from comparable regulatory authorities, reducing duplicative inspections for Indian pharma exporters. India is the world's third-largest pharmaceutical producer by volume and the largest supplier of generic medicines globally. Indian pharma exports face regulatory barriers in developed markets because domestic approvals are not automatically recognized — requiring separate regulatory audits in each destination market.

India's Central Drugs Standard Control Organisation (CDSCO) is the national regulatory authority under the Drugs and Cosmetics Act, 1940
GMP certification from CDSCO or from WHO-GMP programs is the basis on which Indian pharma exporters seek market access
India exports pharmaceutical products to over 200 countries; generics account for approximately 20% of global generic exports by volume
Pharma exports from India in 2024-25: approximately USD 27.9 billion

Connection to this news: The regulatory recognition provision in the India–New Zealand FTA is a non-tariff barrier reduction measure — as significant as tariff elimination for pharmaceutical exporters, since even zero-duty access is nullified if products cannot gain regulatory approval in the destination market.

GATS Mode 4 and India's Services Interests in FTAs

The movement of natural persons to supply services — Mode 4 under the WTO's General Agreement on Trade in Services (GATS, 1995) — is a key negotiating interest for India in all bilateral trade agreements. GATS distinguishes four modes of services supply: Mode 1 (cross-border, e.g., IT services delivered remotely), Mode 2 (consumer travels abroad, e.g., medical tourism), Mode 3 (commercial presence, e.g., a foreign bank branch), and Mode 4 (temporary movement of service suppliers). India's services exports are approximately USD 340 billion (2024-25), making it among the world's top services exporters; IT, business services, and professional services constitute the bulk.

GATS was negotiated as part of the Uruguay Round and entered into force on January 1, 1995
Mode 4 commitments in WTO schedules are generally narrowly drawn; bilateral FTAs allow deeper, more sector-specific commitments
The India–UAE CEPA (2022) also contained a labour mobility chapter, setting a precedent the New Zealand FTA follows
Services trade between India and New Zealand: approximately USD 1.24 billion in 2024, led by travel, IT, and business services

Connection to this news: The 5,000-visa annual quota in the India–New Zealand FTA operationalises Mode 4 commitments in a bilateral context, covering both high-skill professional services (IT, healthcare, engineering) and culturally specific services (yoga instructors, AYUSH practitioners, Indian chefs) — a reflection of India's broadened definition of services trade interests.

Key Facts & Data

First Joint Study Group (India–New Zealand): established 2007
Formal FTA negotiations announced: March 2025
FTA concluded: December 2025 (approximately 9 months)
Formal signing: April 27, 2026
Current bilateral merchandise trade: USD 1.3 billion (2024-25)
Current bilateral services trade: USD 1.24 billion (2024)
Total bilateral trade (goods + services): approximately USD 2.4 billion (2024)
Trade target under FTA: USD 5 billion in 5 years
Investment target: USD 20 billion over 15 years
Indian export coverage: 100% duty-free access in New Zealand
New Zealand import coverage: 95% of tariff lines receive preferential rates
Excluded Indian sectors: dairy, onions, sugar, spices, edible oils, rubber
People-mobility chapter: 5,000 Indian professional visas/year (up to 3-year stays)
Pharma provision: New Zealand to accept GMP/GCP inspection reports from comparable regulators
Agri cooperation: dedicated Agri-Technology Action Plan (kiwifruit, apples, honey focus)
India pharma exports (2024-25): approximately USD 27.9 billion
India services exports (2024-25): approximately USD 340 billion